Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
377.7 USD | -0.91% | -0.71% | +6.33% |
03:01pm | Everest Medicines Commercially Launches Kidney Disease Drug in China | MT |
05-13 | Who are the two iconic Indian spice brands under scrutiny? | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.33% | 16.57B | |
+18.26% | 64.61B | |
+4.99% | 30.63B | |
+13.58% | 11.83B | |
+7.93% | 2.13B | |
+6.72% | 1.79B | |
+9.38% | 1.01B | |
+41.13% | 651M | |
-15.73% | 597M | |
+14.38% | 460M |
- Stock Market
- Equities
- EG Stock
- News Everest Group, Ltd.
- UBS Adjusts Everest Re Group's Price Target to $358 From $327, Maintains Neutral Rating